Search results for "Anticoagulation"
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021
Anticoagulation not superior to placebo for calf DVT in low-risk patients, may increase bleeding risk
The randomized, double-blind, placebo-controlled trial examined a composite measure of extension of calf deep venous thrombosis (DVT) to proximal veins, contralateral proximal DVT, and symptomatic pulmonary embolism in a modified intention-to-treat population.
https://immattersacp.org/weekly/archives/2016/11/15/6.htm
15 Nov 2016
Higher CHADS2 scores can indicate higher risk in patients on anticoagulants
Higher CHADS2 scores pointed to higher risk for adverse outcomes, including stroke, bleeding and death, in patients with atrial fibrillation receiving anticoagulation, according to a new study.
https://immattersacp.org/weekly/archives/2011/11/15/5.htm
15 Nov 2011
Extended anticoagulant treatment prevents recurrent VTE after first unprovoked PE
An additional 18 months of warfarin treatment in patients with first unprovoked PE improves outcomes versus placebo, although the improvement was not sustained after anticoagulant treatment was discontinued.
https://immattersacp.org/weekly/archives/2015/07/14/2.htm
14 Jul 2015
Oral anticoagulation may be associated with decline in renal function in afib patients
Although the findings are most likely not a “game changer,” they may lead physicians to fine-tune their clinical practice.
https://immattersacp.org/weekly/archives/2015/06/09/4.htm
9 Jun 2015
Systematic review compares new and old anticoagulation options for acute VTE
The benefits and risks of 8 different anticoagulation strategies for patients with venous thromboembolism (VTE), including heparin and new oral anticoagulants, were compared in a large new analysis.
https://immattersacp.org/weekly/archives/2014/09/23/7.htm
23 Sep 2014
Anticoagulation for heart failure and afib associated with reductions in mortality, but maybe not readmissions
Starting anticoagulation for older patients with heart failure and atrial fibrillation at hospital discharge was associated with improved mortality at 1 and 3 years but was not associated with improved rates of all-cause cardiovascular readmission or stroke, a study found.
https://immattersacp.org/weekly/archives/2014/09/16/6.htm
16 Sep 2014
Guidance released on use of new oral anticoagulants in nonvalvular afib
The European Heart Rhythm Association published guidance last week on using new oral anticoagulants in patients with nonvalvular atrial fibrillation.
https://immattersacp.org/weekly/archives/2013/05/07/6.htm
7 May 2013
Tailoring anticoagulation more of a reality with DOACs
Direct oral anticoagulants have the potential to replace warfarin for the treatment of many patients with venous thromboembolism, but without a need for routine monitoring, good patient selection is key to their use.
https://immattersacp.org/archives/2018/03/tailoring-anticoagulation-more-of-a-reality-with-doacs.htm
1 Mar 2018
AHA scientific statement offers guidance on LV thrombus
Among other recommendations, clinicians should treat patients with left ventricular (LV) thrombus after myocardial infarction using oral anticoagulants for three months, the American Heart Association (AHA) said.
https://immattersacp.org/weekly/archives/2022/09/20/4.htm
20 Sep 2022